1. Home
  2. DEI vs SLS Comparison

DEI vs SLS Comparison

Compare DEI & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Emmett Inc.

DEI

Douglas Emmett Inc.

HOLD

Current Price

$10.18

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$11.32

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEI
SLS
Founded
1971
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
DEI
SLS
Price
$10.18
$11.32
Analyst Decision
Hold
Buy
Analyst Count
12
2
Target Price
$12.40
★ $32.50
AVG Volume (30 Days)
2.0M
★ 5.0M
Earning Date
11-03-2026
11-11-2026
Dividend Yield
★ 7.47%
N/A
EPS Growth
N/A
★ 50.00
EPS
★ N/A
N/A
Revenue
★ $1,003,982,000.00
N/A
Revenue This Year
$1.79
N/A
Revenue Next Year
$2.61
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.77
N/A
52 Week Low
$9.04
$1.39
52 Week High
$13.32
$15.88

Technical Indicators

Market Signals
Indicator
DEI
SLS
Relative Strength Index (RSI) 53.43 47.50
Support Level $9.30 $10.78
Resistance Level $10.59 $12.62
Average True Range (ATR) 0.32 0.85
MACD 0.12 0.04
Stochastic Oscillator 88.52 54.18

Price Performance

Historical Comparison
DEI
SLS

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: